Gilead Sciences, Inc. GILD shares are trading lower in Tuesday's after-hours session by $3.13 at $70.00 from Tuesday's closing price of $73.13.
The issue isn't being rewarded for its Q4 beat of $0.11 along with a revenue beat of $116 million. The FY 2017 sales guidance of $22.50-$24.50 million and adjusted EPS of $0.84-$0.91 may not compare with prior estimates.
At the end of Tuesday's session, the issue had cleared the sellers lurking at the $73.00 level, finally pushing through as high as $73.30 before the ending the session at $73.13. The buyers of those shares in that area are now deeply in the red.
In extremely volatile trading, the issue briefly spiked to $75.00 on the initial headlines, but sellers flooded the issue. So far, the ensuing decline has taken the issue to $69.80 and now is trying to remain in the $70.00. The after-market low as of 4:28 p.m. ET coincides with its low for it recent decline that was made on January 24 at $69.78.
Gilead hasn't traded under $70.00 since April 2014.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.